tirzepatide shortage news october 18 2025 FDA has announced that the of # tirzepatide, the ingredient in FDA says shortage of popular

Today, we feature Wegovy (semaglutide) a glucagon-like peptide-1 (GLP-1) receptor agonist that was first approved in June 2021 to reduce excess body weight in adults.

In the largest comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data now published in JAMA Internal Medicine Truveta Research found that patients with overweight or obesity taking tirzepatide were three times more likely to achieve 15% weight loss than those taking semaglutide

PlexusDx explains semaglutide dosing, individual response factors, and how to optimize your treatment plan

Learn how to increase GLP-1 naturally using evidence-based nutrition

Patel Helen P

Who Is This For?Whether youre just starting with Semaglutide or Tirzepatide or youre looking for ways to enhance your journey, this guide is for: Individuals seeking healthy, delicious, and practical meal options Those who prefer structure and clear guidance in their meal planning People looking for vegan-friendly options Anyone ready to take control of their health in an empowering way